Does iL-17 induce AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma?
IL-17 mediated tumor-promoting role involves a direct effect on HCC cells through IL-6/JAK2/STAT3 induction by activating the AKT pathway.
Aripiprazole limits inflammatory processes by enhancing anti-inflammatory signaling. Aripiprazole also reduces the risk of metabolic abnormalities.